{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:51:12Z","timestamp":1769273472769,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the huge efforts employed to implement novel chemotherapeutic paradigms for lung cancer,\u00a0the disease still remains a major concern worldwide. Targeting molecular pathways\u00a0as Hedgehog (Hh) and Mitogen-activated protein kinase (MAPK) represent a new hope in lung cancer treatment. This work was undertaken to evaluate the antitumor effects of\u00a0GANT61 (5\u00a0\u03bcM), BI-847325(30\u00a0\u03bcM), and GANT61 (5\u00a0\u03bcM)\/BI-847325(30\u00a0\u03bcM) combination on A549 adenocarcinoma lung cancer cell line. The growth inhibition 50 (GI50) for both drugs was performed using\u00a0MTT. The protein levels of Caspase-3,\u00a0Bcl-2-associated X protein (Bax), Myeloid cell leukemia sequence 1 (MCL-1), cyclin D1, vascular endothelial growth factor (VEGF), extracellular signal-regulated kinases (ERK), p-Akt, and phosphohistone H3 (pHH3) were measured using ELISA. Glioma-associated oncogene homolog 1(<jats:italic>Gli1<\/jats:italic>) gene expression was assessed by quantitative real-time PCR. The GI50 for GANT61 and BI-8473255 were 5\u00a0\u00b5M and 30\u00a0\u00b5M, respectively. Caspase-3 and Bax protein levels were significantly elevated while MCL-1, cyclin D1, VEGF, ERK 1\/2, p-Akt, and pHH3\u00a0levels were significantly reduced by both drugs and their combination relative to the control group.\u00a0<jats:italic>Gli1<\/jats:italic>\u00a0gene expression was down-regulated in all\u00a0groups relative to the control group. GANT61, BI-847325 and their combination inhibited proliferation and angiogenesis but activated the apoptotic pathway. Both drugs conferred a profound negative impact on the crosstalk between each of Hh and MAPK pathways and\u00a0Phosphoinositide <jats:italic>3\u00a0<\/jats:italic>-kinases (PI3K)\/Akt\/Mammalian target of Rapamycin (mTOR). To the best of our knowledge, the antitumor effects of BI-847325\/GANT61 combination have not been tested before. Further in-vitro\u00a0and\u00a0in-vivo\u00a0studies are warranted to support the findings.<\/jats:p>","DOI":"10.1007\/s12032-022-01738-4","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T09:04:55Z","timestamp":1657789495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["GANT61\/BI-847325 combination: a new hope in lung cancer treatment"],"prefix":"10.1007","volume":"39","author":[{"given":"Abdel Halim M.","family":"El-Kishky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8362-9717","authenticated-orcid":false,"given":"Nermine","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maged W.","family":"Helmy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medhat","family":"Haroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"1738_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68:394\u2013424.","journal-title":"Cancer J Clin"},{"key":"1738_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2147\/CEOR.S132259","volume":"9","author":"TR Gildea","year":"2017","unstructured":"Gildea TR, Byfield SD, Hogarth DK, Wilson DS, Quinn CC. A retrospective analysis of delays in the diagnosis of lung cancer and associated costs. ClinicoEcon Outcomes Res. 2017;9:261\u20139.","journal-title":"ClinicoEcon Outcomes Res"},{"issue":"1","key":"1738_CR3","first-page":"110","volume":"2","author":"AM Kabel","year":"2016","unstructured":"Kabel AM. Lung cancer: a focus on the new lines of management. Int J Res Pharm Sci. 2016;2(1):110\u20134.","journal-title":"Int J Res Pharm Sci"},{"issue":"6","key":"1738_CR4","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.18632\/oncotarget.1891","volume":"5","author":"E Shtivelman","year":"2014","unstructured":"Shtivelman E, Hensing T, Simon GR, Dennis PA, Otterson GA, Bueno R, et al. Molecular pathways and therapeutic targets in lung cancer. Oncotarget. 2014;5(6):1392\u2013433.","journal-title":"Oncotarget"},{"key":"1738_CR5","doi-asserted-by":"publisher","first-page":"7969286","DOI":"10.1155\/2016\/7969286","volume":"2016","author":"Y Abe","year":"2016","unstructured":"Abe Y, Tanaka N. The Hedgehog signaling networks in lung cancer: The mechanisms and roles in tumor progression and implications for cancer therapy. Biomed Res Int. 2016;2016:7969286.","journal-title":"Biomed Res Int"},{"issue":"1","key":"1738_CR6","first-page":"1005","volume":"2","author":"M Lin","year":"2016","unstructured":"Lin M. The existence and signaling of cancer stem cells in non-small cell lung cancer. Stem Cell Res. 2016;2(1):1005.","journal-title":"Stem Cell Res"},{"issue":"16","key":"1738_CR7","doi-asserted-by":"publisher","first-page":"13899","DOI":"10.18632\/oncotarget.4224","volume":"6","author":"A Gonnissen","year":"2015","unstructured":"Gonnissen A, Isebaert S, Haustermans K. Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened. Oncotarget. 2015;6(16):13899\u2013913.","journal-title":"Oncotarget"},{"issue":"4","key":"1738_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S2213-2600(15)00026-0","volume":"3","author":"DF Heigener","year":"2015","unstructured":"Heigener DF, Gandara DR, Reck M. Targeting of MEK in lung cancer therapeutics. Lancet Respir Med. 2015;3(4):319\u201327.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"1738_CR9","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s10637-012-9798-6","volume":"30","author":"M Kollareddy","year":"2012","unstructured":"Kollareddy M, Zheleva D, Dzubak P, Brahmkshatriya PS, Lepsik M, Hajduch M. Aurora kinase inhibitors: progress towards the clinic. Invest New Drugs. 2012;30(6):2411\u201332.","journal-title":"Invest New Drugs"},{"issue":"6","key":"1738_CR10","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1158\/1535-7163.MCT-14-0832","volume":"14","author":"MS Phadke","year":"2015","unstructured":"Phadke MS, Sini P, Smalley KS. The novel ATP-competitive MEK\/aurora kinase inhibitor BI-847325 overcomes acquired BRAF inhibitor resistance through suppression of MCL-1 and MEK expression. Mol Cancer Ther. 2015;14(6):1354\u201364.","journal-title":"Mol Cancer Ther"},{"key":"1738_CR11","unstructured":"Riss TL, Moravec RA, Niles AL et al. Cell viability assays. In: Sittampalam GS, Coussens NP, Brimacombe K et al (eds) Assay guidance manual. National Library of Medicine, Bethesda, 2013; 1\u201325."},{"issue":"2","key":"1738_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"T-C Chou","year":"2010","unstructured":"Chou T-C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Can Res. 2010;70(2):440\u20136.","journal-title":"Can Res"},{"issue":"1\u20132","key":"1738_CR13","first-page":"248","volume":"72","author":"M Marion","year":"1976","unstructured":"Marion M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72(1\u20132):248\u201354.","journal-title":"Anal Biochem"},{"issue":"5","key":"1738_CR14","doi-asserted-by":"publisher","first-page":"e63226","DOI":"10.1371\/journal.pone.0063226","volume":"8","author":"O Bermudez","year":"2013","unstructured":"Bermudez O, Hennen E, Koch I, Lindner M, Eickelberg O. Gli1 mediates lung cancer cell proliferation and sonic hedgehog-dependent mesenchymal cell activation. PLoS ONE. 2013;8(5):e63226.","journal-title":"PLoS ONE"},{"key":"1738_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2199-11-61","volume":"11","author":"KM Curtis","year":"2010","unstructured":"Curtis KM, Gomez LA, Rios C, Garbayo E, Raval AP, Perez-Pinzon MA, et al. EF1\u03b1 and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells. BMC Mol Biol. 2010;11:61\u201361.","journal-title":"BMC Mol Biol"},{"issue":"2","key":"1738_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5114\/kitp.2018.76478","volume":"15","author":"A Rybarczyk-Kasiuchnicz","year":"2018","unstructured":"Rybarczyk-Kasiuchnicz A, Ramlau R. Current views on molecularly targeted therapy for lung cancer\u2014a review of literature from the last five years. Polish J Cardio Thorac Surg. 2018;15(2):119\u201324.","journal-title":"Polish J Cardio Thorac Surg"},{"issue":"21","key":"1738_CR17","doi-asserted-by":"publisher","first-page":"9736","DOI":"10.1073\/pnas.1004602107","volume":"107","author":"EY Lee","year":"2010","unstructured":"Lee EY, Ji H, Ouyang Z, Zhou B, Ma W, Vokes SA, et al. Hedgehog pathway-regulated gene networks in cerebellum development and tumorigenesis. Proc Natl Acad Sci USA. 2010;107(21):9736\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1738_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.semcancer.2015.08.003","volume":"35","author":"E Rovida","year":"2015","unstructured":"Rovida E, Stecca B. Mitogen-activated protein kinases and Hedgehog-GLIsignaling in cancer: a crosstalk providing therapeutic opportunities? Semin Cancer Biol. 2015;35:154\u201367.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"1738_CR19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/mc.20516","volume":"48","author":"M Seto","year":"2009","unstructured":"Seto M, Ohta M, Asaoka Y, Ikenoue T, Tada M, Miyabayashi K, et al. Regulation of the hedgehog signaling by the mitogen-activated protein kinase cascade in gastric cancer. Mol Carcinog. 2009;48(8):703\u201312.","journal-title":"Mol Carcinog"},{"key":"1738_CR20","doi-asserted-by":"publisher","first-page":"40361","DOI":"10.1038\/srep40361","volume":"7","author":"H Liang","year":"2017","unstructured":"Liang H, Zheng Q-L, Fang P, Zhang J, Zhang T, Liu W, et al. Targeting the PI3K\/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells. Sci Rep. 2017;7:40361.","journal-title":"Sci Rep"},{"issue":"21","key":"1738_CR21","doi-asserted-by":"publisher","first-page":"15390","DOI":"10.1074\/jbc.M112.425249","volume":"288","author":"NK Agarwal","year":"2013","unstructured":"Agarwal NK, Qu C, Kunkulla K, Liu Y, Vega F. Transcriptional regulation of serine\/threonine protein kinase (AKT) genes by glioma-associated oncogene homolog 1. J Biol Chem. 2013;288(21):15390\u2013401.","journal-title":"J Biol Chem"},{"issue":"6","key":"1738_CR22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","volume":"36","author":"MC Mendoza","year":"2011","unstructured":"Mendoza MC, Blenis J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci. 2011;36(6):320\u20138.","journal-title":"Trends Biochem Sci"},{"issue":"13","key":"1738_CR23","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-11-3747","volume":"72","author":"AB Turke","year":"2012","unstructured":"Turke AB, Song Y, Costa C, Cook R, Arteaga CL, Asara JM, et al. MEK inhibition leads to PI3K\/AKT activation by relieving a negative feedback on ERBB receptors. Can Res. 2012;72(13):3228\u201337.","journal-title":"Can Res"},{"issue":"1","key":"1738_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1476-4598-8-95","volume":"8","author":"J-E Yao","year":"2009","unstructured":"Yao J-E, Yan M, Guan Z, Pan C-B, Xia L-P, Li C-X, et al. Aurora-A down-regulates IkappaB\u03b1 via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival. Mol Cancer. 2009;8(1):95.","journal-title":"Mol Cancer."},{"key":"1738_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3389\/fonc.2015.00295","volume":"5","author":"AB D\u2019Assoro","year":"2016","unstructured":"D\u2019Assoro AB, Haddad T, Galanis E. Aurora-A kinase as a promising therapeutic target in cancer. Front Oncol. 2016;5:295.","journal-title":"Front Oncol"},{"issue":"5","key":"1738_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/aps.2012.24","volume":"33","author":"J-T Lu","year":"2012","unstructured":"Lu J-T, He W, Wei W. Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway. Acta Pharmacol Sin. 2012;33(5):691\u2013700.","journal-title":"Acta Pharmacol Sin"},{"issue":"16","key":"1738_CR27","doi-asserted-by":"publisher","first-page":"9255","DOI":"10.1073\/pnas.151173398","volume":"98","author":"J Xie","year":"2001","unstructured":"Xie J, Aszterbaum M, Zhang X, Bonifas JM, Zachary C, Epstein E, et al. A role of PDGFR\u03b1 in basal cell carcinoma proliferation. Proc Natl Acad Sci USA. 2001;98(16):9255\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1738_CR28","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.3892\/ol.2016.5110","volume":"12","author":"L Li","year":"2016","unstructured":"Li L, Zhao GD, Shi Z, Qi LL, Zhou LY, Fu ZX. The RAS\/RAF\/MEK\/ERK signaling pathway and its role in the occurrence and development of HCC. Oncol Lett. 2016;12(5):3045\u201350.","journal-title":"Oncol Lett"},{"issue":"8","key":"1738_CR29","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","volume":"1773","author":"JA McCubrey","year":"2007","unstructured":"McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, et al. Roles of the RAF\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 2007;1773(8):1263\u201384.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"1738_CR30","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s00432-016-2241-1","volume":"142","author":"Z Lin","year":"2016","unstructured":"Lin Z, Li S, Sheng H, Cai M, Ma LYS, Hu L, et al. Suppression of GLIsensitizes medulloblastoma cells to mitochondria-mediated apoptosis. J Cancer Res Clin Oncol. 2016;142(12):2469\u201378.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1738_CR31","doi-asserted-by":"publisher","first-page":"41574","DOI":"10.1038\/srep41574","volume":"7","author":"K-Y Chen","year":"2017","unstructured":"Chen K-Y, Chiu C-H, Wang L-C. Anti-apoptotic effects of Sonic hedgehog signalling through oxidative stress reduction in astrocytes co-cultured with excretory-secretory products of larval Angiostrongylus cantonensis. Sci Rep. 2017;7:41574.","journal-title":"Sci Rep"},{"issue":"1","key":"1738_CR32","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.bbrc.2017.08.164","volume":"493","author":"J Li","year":"2017","unstructured":"Li J, Zhang L, Xia Q, Fu J, Zhou Z, Lin F. Hedgehog signaling inhibitor GANT61 induces endoplasmic reticulum stress-mediated protective autophagy in hepatic stellate cells. Biochem Biophys Res Commun. 2017;493(1):487\u201393.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1738_CR33","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3892\/or.2014.2986","volume":"31","author":"Z Jiang","year":"2014","unstructured":"Jiang Z, Jiang J, Yang H, Ge Z, Wang Q, Zhang L, et al. Silencing of Aurora kinase A by RNA interference inhibits tumor growth in human osteosarcoma cells by inducing apoptosis and G2\/M cell cycle arrest. Oncol Rep. 2014;31(3):1249\u201354.","journal-title":"Oncol Rep"},{"issue":"1","key":"1738_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12943-016-0509-3","volume":"15","author":"A Hanna","year":"2016","unstructured":"Hanna A, Shevde LA. Hedgehog signaling: modulation of cancer properties and tumor mircroenvironment. Mol Cancer. 2016;15(1):24.","journal-title":"Mol Cancer"},{"issue":"2","key":"1738_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.352","volume":"8","author":"K Qu","year":"2017","unstructured":"Qu K, Wang Z, Fan H, Li J, Liu J, Li P, et al. MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma. Cell Death Dis. 2017;8(2): e2603.","journal-title":"Cell Death Dis"},{"issue":"39","key":"1738_CR36","doi-asserted-by":"publisher","first-page":"65064","DOI":"10.18632\/oncotarget.17775","volume":"8","author":"J-Y Kim","year":"2017","unstructured":"Kim J-Y, Jeong HS, Chung T, Kim M, Lee JH, Jung WH, et al. The value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: a comparative study with Ki67. Oncotarget. 2017;8(39):65064\u201376.","journal-title":"Oncotarget"},{"issue":"3","key":"1738_CR37","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1101\/lm.152906","volume":"13","author":"WB Chwang","year":"2006","unstructured":"Chwang WB, O\u2019Riordan KJ, Levenson JM, Sweatt JD. ERK\/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. Learn Mem. 2006;13(3):322\u20138.","journal-title":"Learn Mem"},{"issue":"5","key":"1738_CR38","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/jmcb\/mjs043","volume":"4","author":"T Suganuma","year":"2012","unstructured":"Suganuma T, Workman JL. MAP kinases and histone modification. J Mol Cell Biol. 2012;4(5):348\u201350.","journal-title":"J Mol Cell Biol"},{"issue":"17","key":"1738_CR39","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1158\/1078-0432.CCR-12-0599","volume":"18","author":"Y Shi","year":"2012","unstructured":"Shi Y, Moura U, Opitz I, Soltermann A, Rehrauer H, Thies S, et al. Role of hedgehog signaling in malignant pleural mesothelioma. Clin Cancer Res. 2012;18(17):4646\u201356.","journal-title":"Clin Cancer Res"},{"key":"1738_CR40","unstructured":"Vu H-L, Nguyen C-H and Molla A. Basal aurora kinase B activity is sufficient for histone H3 phosphorylation in prophase. Biology Open. 2013; 7(5): BIO20133079."},{"key":"1738_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4137\/OED.S32200","volume":"8","author":"SV Kyosseva","year":"2016","unstructured":"Kyosseva SV. Targeting MAPK signaling in age-related macular degeneration. Ophthalmol Eye Dis. 2016;8:23\u201330.","journal-title":"Ophthalmol Eye Dis"},{"issue":"21","key":"1738_CR42","doi-asserted-by":"publisher","first-page":"6351","DOI":"10.1158\/1078-0432.CCR-06-1252","volume":"12","author":"J Lee","year":"2006","unstructured":"Lee J, Park SY, Lee EK, Park CG, Chung HC, Rha SY, et al. Activation of Hypoxia-Inducible Factor-1\u03b1 Is Necessary for Lysophosphatidic Acid-Induced Vascular Endothelial Growth Factor Expression. Clin Cancer Res. 2006;12(21):6351\u20138.","journal-title":"Clin Cancer Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01738-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-022-01738-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-022-01738-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T04:22:26Z","timestamp":1661142146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-022-01738-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["1738"],"URL":"https:\/\/doi.org\/10.1007\/s12032-022-01738-4","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"assertion":[{"value":"23 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u2018No relevant financial or non-financial interests to disclose. The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be considered as a potential conflict of interest\u2019.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"\u2018The current research has followed accepted principles of ethical and professional conduct according to the approval by the Research Ethics Committee of the Institute of Graduate Studies and Research, Alexandria University\u2019.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"144"}}